In hepatocellular carcinoma (HCC) and gastric cancer, miR-26a-5p expression has been reported to inhibit proliferation, migration, and invasion by downregulating oncogenic signaling pathways (e.g., the HGF-Met and COL10A1 pathways) [36, 37]. The gene discussed is MET; the disease is gastric cancer.